| Product Code: ETC7923141 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Latvia therapeutic vaccines import market in 2024 saw significant contributions from top exporting countries such as Metropolitan France, Germany, Lithuania, Poland, and the USA. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, potentially leading to competitive challenges. Despite a remarkable compound annual growth rate (CAGR) of 43.42% from 2020 to 2024, the negative growth rate of -57.01% in 2024 suggests a recent decline in import volumes, signaling a need for further analysis and strategic adjustments in the market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Therapeutic Vaccines Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Therapeutic Vaccines Market Revenues & Volume, 2022 & 2032F |
3.3 Latvia Therapeutic Vaccines Market - Industry Life Cycle |
3.4 Latvia Therapeutic Vaccines Market - Porter's Five Forces |
3.5 Latvia Therapeutic Vaccines Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Latvia Therapeutic Vaccines Market Revenues & Volume Share, By Therapeutic Vaccines, 2022 & 2032F |
4 Latvia Therapeutic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Latvia leading to a growing demand for therapeutic vaccines |
4.2.2 Rising government initiatives to promote vaccination programs and healthcare accessibility in Latvia |
4.2.3 Advancements in technology and research leading to the development of more effective therapeutic vaccines |
4.3 Market Restraints |
4.3.1 High costs associated with research and development of therapeutic vaccines impacting market growth |
4.3.2 Stringent regulatory requirements and approval processes for therapeutic vaccines in Latvia |
5 Latvia Therapeutic Vaccines Market Trends |
6 Latvia Therapeutic Vaccines Market, By Types |
6.1 Latvia Therapeutic Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Therapeutic Vaccines Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Latvia Therapeutic Vaccines Market Revenues & Volume, By Peptide Therapeutic Vaccine, 2022 - 2032F |
6.1.4 Latvia Therapeutic Vaccines Market Revenues & Volume, By Cell Therapeutic Vaccine, 2022 - 2032F |
6.1.5 Latvia Therapeutic Vaccines Market Revenues & Volume, By Nucleic Acid Therapeutic Vaccine, 2022 - 2032F |
6.2 Latvia Therapeutic Vaccines Market, By Therapeutic Vaccines |
6.2.1 Overview and Analysis |
6.2.2 Latvia Therapeutic Vaccines Market Revenues & Volume, By Oncotherapy, 2022 - 2032F |
6.2.3 Latvia Therapeutic Vaccines Market Revenues & Volume, By Hepatitis B, 2022 - 2032F |
6.2.4 Latvia Therapeutic Vaccines Market Revenues & Volume, By Tuberculosis, 2022 - 2032F |
6.2.5 Latvia Therapeutic Vaccines Market Revenues & Volume, By Herpes Simplex Virus, 2022 - 2032F |
6.2.6 Latvia Therapeutic Vaccines Market Revenues & Volume, By Others, 2022 - 2032F |
7 Latvia Therapeutic Vaccines Market Import-Export Trade Statistics |
7.1 Latvia Therapeutic Vaccines Market Export to Major Countries |
7.2 Latvia Therapeutic Vaccines Market Imports from Major Countries |
8 Latvia Therapeutic Vaccines Market Key Performance Indicators |
8.1 Number of clinical trials conducted for therapeutic vaccines in Latvia |
8.2 Percentage of population vaccinated with therapeutic vaccines |
8.3 Investment in research and development of therapeutic vaccines in Latvia |
9 Latvia Therapeutic Vaccines Market - Opportunity Assessment |
9.1 Latvia Therapeutic Vaccines Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Latvia Therapeutic Vaccines Market Opportunity Assessment, By Therapeutic Vaccines, 2022 & 2032F |
10 Latvia Therapeutic Vaccines Market - Competitive Landscape |
10.1 Latvia Therapeutic Vaccines Market Revenue Share, By Companies, 2025 |
10.2 Latvia Therapeutic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here